Artemisia annua Sublingual Immunotherapy Is Efficacious and Well Tolerated in Patients With Season Allergic Rhinitis: A Prospective, Open‐Label, Multicenter Phase IV Trial

Allergy: European Journal of Allergy and Clinical Immunology · Published 2026-07-28 · DOI 10.1111/all.70462

Authors (11)

Yunbo Gao, Xueyan Wang, Jinmei Xue, Xiaoyue Wang, Huanping Zhang, Shuxin Wen, Fang Quan, Zhimin Xing, Boqian Wang, Luo Zhang, Yuan Zhang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Gao, Y., Wang, X., Xue, J., et al. (2026). Artemisia annua Sublingual Immunotherapy Is Efficacious and Well Tolerated in Patients With Season Allergic Rhinitis: A Prospective, Open‐Label, Multicenter Phase IV Trial. Allergy: European Journal of Allergy and Clinical Immunology. https://doi.org/10.1111/all.70462

Related articles